Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential - Wikidata - wikimedia - TriplyDB

Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential

Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential

http://www.wikidata.org/entity/Q28296240

about

Envelope glycoprotein of arenaviruses Ambroxol in the 21st century: pharmacological and clinical update Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.

P2860

Q24613392-E8B28A12-63BF-4211-80F4-CBA88351AC3F Q28289778-F4D92B1A-18FC-4890-A49A-E982BF4FAE25 Q33516234-B8B9BFD7-83EA-451F-B0C2-BEA620171CA5 Q33983140-E9653795-34C9-42E5-90AD-D6A371FC9BC5 Q37576058-AADDAF19-C646-43D8-9E27-6D460DCF6B2A

P2860

Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential

http://www.wikidata.org/entity/Q28296240

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Secretory leukoprotease inhibi ...... may have therapeutic potential

@ast

Secretory leukoprotease inhibi ...... may have therapeutic potential

@en

Secretory leukoprotease inhibi ...... may have therapeutic potential

@nl

type

label

Secretory leukoprotease inhibi ...... may have therapeutic potential

@ast

Secretory leukoprotease inhibi ...... may have therapeutic potential

@en

Secretory leukoprotease inhibi ...... may have therapeutic potential

@nl

prefLabel

Secretory leukoprotease inhibi ...... may have therapeutic potential

@ast

Secretory leukoprotease inhibi ...... may have therapeutic potential

@en

Secretory leukoprotease inhibi ...... may have therapeutic potential

@nl

P1433

Q28296240-C61C4477-219A-4CA9-BE30-4C10ACB0F426

P1476

Q28296240-4C07747E-ED1B-403E-A5D5-173B6661F525

P2093

Q28296240-085FE6E6-9F6E-4E88-A639-275E429934F8

Q28296240-132AD171-D040-405F-8728-69A7CC2F8266

Q28296240-266E0DBF-50D5-4A3D-A2BE-355728147639

Q28296240-2BEB2D31-B366-49D5-865C-B7CD4C266923

Q28296240-6D809A93-786D-4118-960E-51A633D332A1

Q28296240-EDFD0575-B749-4EDE-9C2E-A7E6020F07E9

P2860

Q28296240-03826FC9-01B9-47A6-9F6A-DC4BC6E14869

Q28296240-12DE538F-BD15-4BFD-B570-0B55F8BCEEDD

Q28296240-1EEE9A73-71D5-478B-8100-2804A1178E36

Q28296240-37D0F40B-E86D-44C3-98E4-FF64153F6730

Q28296240-38D03E6C-BB95-434E-B0E8-073CCC20F639

Q28296240-43B71615-E388-424A-AAF8-7F2B17D2F242

Q28296240-60DEDB14-4A8F-4548-883D-E79A5CB19BF0

Q28296240-7840069E-614A-4021-AC78-ACE158BAD74F

Q28296240-90E6526A-16FC-44BA-AF0E-35E27F085617

Q28296240-95D03C4B-FCF7-4476-A6D5-8498EAA096B9

P304

Q28296240-3D96A7BA-A9DC-4FA9-9721-AC521A75AFF1

P31

Q28296240-92D86867-1B9A-40B8-AAD2-2EFC36E98858

P356

Q28296240-BEA21A2B-90D2-4068-990B-A17DDD433E18

P407

Q28296240-E1472F4D-5BE4-46F6-801B-645E36D69B73

P433

Q28296240-3B714C34-AA85-4D2B-9D6B-6C405655A3B9

P478

Q28296240-07DC9AAF-8190-4644-B3AF-CED7D8A1A1CC

P577

Q28296240-DDD00427-3370-423C-8EAE-3CD861A245A7

P698

Q28296240-40711253-3F0D-47C3-A51B-9D127A2555B8

P356

P1433

Biological Chemistry

P1476

Secretory leukoprotease inhibi ...... may have therapeutic potential

@en

P2093

Dai Mizuno

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kido

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yamada

http://www.w3.org/2001/XMLSchema#string

Mihiro Yano

http://www.w3.org/2001/XMLSchema#string

Youichirou Higashi

http://www.w3.org/2001/XMLSchema#string

Yuushi Okumura

http://www.w3.org/2001/XMLSchema#string

P2860

Accumulation of mini-plasmin in the cerebral capillaries causes vascular invasion of the murine brain by a pneumotropic influenza A virus: implications for influenza-associated encephalopathy

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Host cell proteases controlling virus pathogenicity.

Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization.

Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung

Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs.

Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.

Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels.

A novel influenza A virus activating enzyme from porcine lung: purification and characterization.

Distribution of secretory leukoprotease inhibitor in the human nasal airway.

P304

1029-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/BC.2004.133

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

385

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15576322

http://www.w3.org/2001/XMLSchema#string